Inventor
MCCARTHY CLIVE
GB44 patents
⚠️ This page may combine multiple inventors who share the name “MCCARTHY CLIVE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
11 patentsUS7947730B2May 24, 2011
Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
NOVARTIS AG7 citations84
US8865894B2Oct 21, 2014
Oxazolidin-2-one compounds and uses thereof
NOVARTIS AG10 citations81
US7273875B2Sep 25, 2007
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors
NOVARTIS AG10 citations79
US7468370B2Dec 23, 2008
[1,7]naphthyridines as PDE4 inhibitors
NOVARTIS AG6 citations71
US7687637B2Mar 30, 2010
5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
NOVARTIS AG7 citations70
US8030311B2Oct 4, 2011
Phenylacetamides suitable as protein kinase inhibitors
NOVARTIS AG2 citations63
US7288537B2Oct 30, 2007
Azetidine derivatives as CCR-3 receptor antagonists
NOVARTIS AG4 citations56
US7902375B2Mar 8, 2011
5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases
NOVARTIS AG1 citations50
US8039455B2Oct 18, 2011
Macrocyclic compounds useful as BACE inhibitors
NOVARTIS AG0 citations39
US8017608B2Sep 13, 2011
5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
NOVARTIS AG0 citations36
US7754758B2Jul 13, 2010
Pyrrolidine derivatives acting as CCR3-receptor antagonists
NOVARTIS AG0 citations36
ENTERPRISE THERAPEUTICS LTD
6 patentsUS12037336B2Jul 16, 2024
Compounds with activity as inhibitors of the epithelial sodium channel (ENaC)
ENTERPRISE THERAPEUTICS LTD3 citations71
US12371436B2Jul 29, 2025
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US11739094B2Aug 29, 2023
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US10941149B2Mar 9, 2021
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US11370778B2Jun 28, 2022
Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases
ENTERPRISE THERAPEUTICS LTD0 citations48
US10759785B2Sep 1, 2020
Compounds
ENTERPRISE THERAPEUTICS LTD0 citations37
AVENTIS PHARMA LTD
5 patentsUS6608084B1Aug 19, 2003
Aza-bicycles which modulate the inhibition of cell adhesion
AVENTIS PHARMA LTD67 citations95
US6706738B2Mar 16, 2004
Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
AVENTIS PHARMA LTD20 citations82
US6562851B2May 13, 2003
Substituted bicyclic compounds
AVENTIS PHARMA LTD8 citations72
US6593354B2Jul 15, 2003
Substituted benzoxazole compounds
AVENTIS PHARMA LTD4 citations61
US6762199B2Jul 13, 2004
Indane derivatives
AVENTIS PHARMA LTD0 citations36
BOEHRINGER INGELHEIM INT
5 patentsUS9845314B2Dec 19, 2017
Pyrazolyl-substituted heteroaryls and their use as medicaments
BOEHRINGER INGELHEIM INT4 citations70
US10947243B2Mar 16, 2021
Heteroaryl SYK inhibitors
BOEHRINGER INGELHEIM INT0 citations56
US10155751B2Dec 18, 2018
Pyrazolyl-substituted heteroaryls and their use as medicaments
BOEHRINGER INGELHEIM INT0 citations51
US9199937B2Dec 1, 2015
Substituted quinolines and their use as medicaments
BOEHRINGER INGELHEIM INT0 citations49
US9914735B2Mar 13, 2018
Heteroaryl Syk inhibitors
BOEHRINGER INGELHEIM INT0 citations47
RHONE POULENC RORER LTD
3 patentsUS6211234B1Apr 3, 2001
Substituted phenyl compounds
RHONE POULENC RORER LTD26 citations88
US6124343ASep 26, 2000
Substituted phenyl compounds with a substituent having a thienyl ring
RHONE POULENC RORER LTD12 citations69
US6048893AApr 11, 2000
Substituted phenyl compounds with a substituent having A 1,3-benzodioxole ring
RHONE POULENC RORER LTD3 citations58
TMEM16A LTD
3 patentsORCA PHARMACEUTICALS LTD
3 patentsUS10383850B2Aug 20, 2019
Indazole and indole derivatives as inhibitors of retinoic acid related orphan receptor gamma (ROR gamma) for the treatment of immune-related diseases
ORCA PHARMACEUTICALS LTD0 citations45
US9861612B2Jan 9, 2018
Indolyl-containing RORγt inhibitors
ORCA PHARMACEUTICALS LTD0 citations45
US9522134B2Dec 20, 2016
Compounds
ORCA PHARMACEUTICALS LTD0 citations45